化合物CS-2660 (JNJ-38158471) T22349

Product Introduction
Bioactivity


英文名: JNJ-38158471

描述: JNJ-38158471 (CS-2660) 是一种耐受性好的，有口服活性的、高效的、选择性的 VEGFR-2抑制剂 (IC50:40 nM)，还能抑制 Ret (IC50:180 nM) 和 Kit (IC50:500 nM)。

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 30 mg/ml (82.24 mM)


关键字: VEGFR-2 | VEGFR | cancer | SCFR | JNJ 38158471 | malignancies | CS 2660 | JNJ-38158471 | Kit | c-Kit | CD117 | RET | Vascular endothelial growth factor receptor | inhibit | CS2660 | JNJ38158471 | Inhibitor

相关产品: Icrucumab | VEGFR-2-IN-35 | PP121 | PHA-665752 | Regorafénib N-oxyde (M2) | Ilorasertib | CP-547632 | ENMD-2076 | AKB-6899 | Lenvatinib mesylate

相关库: Anti-Prostate Cancer Compound Library | Anti-Breast Cancer Compound Library | Membrane Protein-targeted Compound Library | Anti-Ovarian Cancer Compound Library | Kinase Inhibitor Library | Inhibitor Library | Tyrosine Kinase Inhibitor Library | Highly Selective Inhibitor Library | Anti-Pancreatic Cancer Compound Library | NO PAINS Compound Library

化合物CS-2660 (JNJ-38158471) T22349信息由TargetMol中国为您提供，如您想了解更多关于化合物CS-2660 (JNJ-38158471) T22349报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途